<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Four_Exceptional_Simple_Steps_For_Bortezomib</id>
		<title>Four Exceptional Simple Steps For Bortezomib - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Four_Exceptional_Simple_Steps_For_Bortezomib"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Four_Exceptional_Simple_Steps_For_Bortezomib&amp;action=history"/>
		<updated>2026-05-15T09:09:53Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Four_Exceptional_Simple_Steps_For_Bortezomib&amp;diff=122246&amp;oldid=prev</id>
		<title>Shirt65link: Створена сторінка: In the study from Taiwan,18 the immunogenicity of a weight-based immunization policy was retrospectively assessed in 155 preterm infants with a birth weight of?...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Four_Exceptional_Simple_Steps_For_Bortezomib&amp;diff=122246&amp;oldid=prev"/>
				<updated>2016-12-17T14:27:56Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: In the study from Taiwan,18 the immunogenicity of a weight-based immunization policy was retrospectively assessed in 155 preterm infants with a birth weight of?...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;In the study from Taiwan,18 the immunogenicity of a weight-based immunization policy was retrospectively assessed in 155 preterm infants with a birth weight of? 24 hours after birth and their first active immunization at a mean age of 57.8 days when they had reached a body weight of 2,000 to 2,200 g. Of the 20 infants born to HBsAg-positive/HBeAg-negative mothers, 12 also received HBIG immediately after birth and 8 did not. Mean age when [http://www.selleckchem.com/products/gsk1120212-jtp-74057.html Trametinib] the first dose of hepatitis B vaccine was administered in these 20 infants was 81.5 days. All 26 infants received 2 subsequent doses of hepatitis B vaccine 1 and 6 months after the first dose and none of them was positive for HBsAg or anti-HBc at follow-up. Contact with manufacturers of hepatitis B vaccines (GSK and Sanofi Pasteur MSD) did not reveal unpublished data relevant to the topic of this review. Discussion We present the case of an extremely LBW and growth-retarded infant born to a HBsAg-positive mother in whom we applied a four-dose active immunization schedule at 0, 1, 2, and 12 months of age in addition to administration of HBIG at [https://en.wikipedia.org/wiki/Tuclazepam tuclazepam] birth. Protective anti-HBs serum antibody values (&amp;gt; 100 IU/L) were detected after the third and fourth vaccination. To our knowledge, this is the smallest preterm infant with successful hepatitis B immunization and prevention of vertical virus transmission ever reported in the literature. This experience prompted us to perform a review on the effect of hepatitis B postexposure prophylaxis in preterm and LBW infants, including transmission rate and antibody response outcomes. Although the search strategy could not identify any study specifically evaluating the effect of hepatitis B postexposure vaccine schedules in preterm and LBW infants, the three included [http://www.selleckchem.com/products/Bortezomib.html Bortezomib in vivo] studies together provided data on seroprotection results in 80 LBW and preterm infants (&lt;/div&gt;</summary>
		<author><name>Shirt65link</name></author>	</entry>

	</feed>